GlaxoSmithKline PLC (GSK) | Common-Size Income Statement
See also
- Johnson & Johnson (JNJ), Common-Size Income Statement
- Pfizer Inc. (PFE), Common-Size Income Statement
- Novartis AG (NVS), Common-Size Income Statement
- Merck & Co. Inc. (MRK), Common-Size Income Statement
- Abbott Laboratories (ABT), Common-Size Income Statement
- Sanofi (SNY), Common-Size Income Statement
- Novo Nordisk A/S (NVO), Common-Size Income Statement
- UnitedHealth Group Inc. (UNH), Common-Size Income Statement
- Bristol-Myers Squibb Co. (BMY), Common-Size Income Statement
- AstraZeneca PLC (AZN), Common-Size Income Statement
- Eli Lilly & Co. (LLY), Common-Size Income Statement
- Medtronic Inc. (MDT), Common-Size Income Statement
- Baxter International Inc. (BAX), Common-Size Income Statement
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
GlaxoSmithKline PLC, Common-Size Consolidated Income Statement
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Turnover | |
|
|
|
|
|
Cost of sales | |
|
|
|
|
|
Gross profit | % |
% |
% |
% |
% |
|
Selling, general and administration | |
|
|
|
|
|
Research and development | |
|
|
|
|
|
Royalty income | |
|
|
|
|
|
Milestone income | |
|
|
|
|
|
Impairment of equity investments | |
|
|
|
|
|
Disposal of equity investments | |
|
|
|
|
|
Disposal of businesses, other assets and legal settlements | |
|
|
|
|
|
Gain recognised on creation of ViiV Healthcare | |
|
|
|
|
|
Fair value adjustments on derivative financial instruments | |
|
|
|
|
|
Other income | |
|
|
|
|
|
Other operating income | % |
% |
% |
% |
% |
|
Operating profit | % |
% |
% |
% |
% |
|
Interest income | |
|
|
|
|
|
Realised gains on liquid investments | |
|
|
|
|
|
Fair value movements on derivatives at fair value through profit or loss | |
|
|
|
|
|
Finance income | % |
% |
% |
% |
% |
|
Interest expense | |
|
|
|
|
|
Fair value hedges | |
|
|
|
|
|
Fair value movements on other derivatives at fair value through profit or loss | |
|
|
|
|
|
Reclassification of cash flow hedge from other comprehensive income | |
|
|
|
|
|
Unwinding of discounts on provisions | |
|
|
|
|
|
Movements on amounts owed to non-controlling interests | |
|
|
|
|
|
Other finance expense | |
|
|
|
|
|
Finance costs | % |
% |
% |
% |
% |
|
Profit on disposal of interest in associates | |
|
|
|
|
|
Share of after tax profits of associates and joint ventures | |
|
|
|
|
|
Profit before taxation | % |
% |
% |
% |
% |
|
Taxation | |
|
|
|
|
|
Profit after taxation for the year | % |
% |
% |
% |
% |
|
Profit attributable to non-controlling interests | |
|
|
|
|
|
Profit attributable to shareholders | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center